ATOMOXETINE
Tracking # 20-816699
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
ATOMOXETINE IS INDICATED FOR THE TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN ADULTS AND CHILDREN OVER THE AGE OF 6. ALTHOUGH ATOMOXETINE IS ONLY FDA APPROVED FOR THE TREATMENT OF ADHD, IT IS SOMETIMES USED OFF-LABEL FOR THE TREATMENT OF ADULT PATIENTS WITH TREATMENT-RESISTANT DEPRESSION. THIS ACTIVITY OUTLINES THE INDICATIONS, MECHANISM OF ACTION, SAFE ADMINISTRATION, ADVERSE EFFECTS, CONTRAINDICATIONS, AND MONITORING OF ATOMOXETINE.
Subject areas
This course counts toward the state boards and subject areas below.
Bahamas Medical Council
Specialty Medical Practitioner
1.25h
General Medicine
Louisiana State Board of Medical Examiners - Physicians & Surgeons
Physician & Surgeon
1.25h
Category I CME
Mississippi State Board of Medical Licensure
Medical Doctor
1.25h
AMA Category I
Physician Assistant
1.25h
AMA Category I
State Medical Board of Ohio
Doctor of Medicine
1.25h
AMA Category I